Pharmaceuticals
‘Backfired’: Ozempic maker’s disastrous trial and its $US475 billion meltdown
Analysts say Novo Nordisk’s new obesity drug may be obsolete before it hits the shelves, underlining a massive fall from grace for the company behind the weight loss boom.
- Colin Kruger
Latest
‘My future crumbled’: Amanda joins class action over baby powder’s claimed link to cancer
A class action of 1300 women has started against pharmaceutical giant Johnson & Johnson.
- Kayla Olaya
Boss of $83b giant CSL exits abruptly
Australian pharmaceuticals heavyweight CSL says its chief executive Paul McKenzie is leaving the company with immediate effect.
- Clancy Yeates
Statins don’t cause the majority of ‘side effects’ on the label
These life-saving medications have been blamed for a laundry list of side effects. They’ve just been vindicated.
- Kate Aubusson
‘Not for human consumption’: Warning to Australians injecting bootlegged weight-loss drug
The website says “for research use only”, then they ship it to suburban homes.
- Kate Aubusson
- Exclusive
- Healthcare
When Anthony began taking a popular hair loss drug, the side effects emerged almost immediately
As Gen Zs and Millennials turn to digital subscription services for hair loss, doctors are warning men to consult a GP in person and use additional safeguards.
- Broede Carmody
- Updated
- Trade deals
Australia in talks with US over Trump demands to pay more for medicine
A White House official said the general structure of the deal – under which other countries pay more for medicines or face punitive trade measures – was the model for talks with other nations.
- Michael Koziol and Natassia Chrysanthos
Queensland to allow GPs to diagnose, prescribe ADHD drugs to adults
Health Minister Tim Nicholls touted the move as a “nation-leading first” in treating ADHD in Australia.
- Alex Condon
- Exclusive
- Trade wars
Mission critical: Australia keen to lock in new US deal before Trump meeting
Canberra is negotiating with the president’s lieutenants to guarantee the Americans access to the elements needed to build everything from smartphones to fighter jets.
- Paul Sakkal and Nick Newling
Break ground by Wednesday or else: Trump imposes 100 per cent tariff on pharmaceuticals
Shares in domestic biotechnology giant CSL dropped 3.6 per cent after Trump announced the tariff on Truth Social.
- Nick Newling